GCP
IMMX icon

GSA Capital Partners’s Immix Biopharma IMMX Stock Holding History

GSA Capital Partners’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Buy
+17,817
New +$131K 0.01% 1499

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

GSA Capital Partners's IMMX Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Immix Biopharma (IMMX) in Q1 2026: 17,817 shares worth $162K. The stake represents 0.01% of the portfolio and ranks #1499 among its holdings.

77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • GSA Capital Partners held 17,817 shares of Immix Biopharma worth $162K as of Q1 2026.
  • Immix Biopharma was a new GSA Capital Partners position in Q1 2026.
  • Immix Biopharma made up 0.01% of GSA Capital Partners's portfolio in Q1 2026, its #1499 holding.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.